Morpholino

MO5-pink1

ID

ZDB-MRPHLNO-101007-5

Name

MO5-pink1

Previous Names

exon 3 intron 3 (1)

Target

pink1 (1)

Sequence

5' - TCACAACCTACCCGTTCAAAGTCAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO5-pink1

No data available

Phenotype

Phenotype resulting from MO5-pink1

Phenotype	Fish	Figures
brain proliferative region increased size, abnormal	WT + MO5-pink1	Fig. 2 from Priyadarshini et al., 2013
catalase activity decreased process quality, abnormal	WT + MO5-pink1	Fig. 4 from Priyadarshini et al., 2013
diencephalon dopaminergic neuron decreased amount, abnormal	WT + MO5-pink1	Fig. 4, Fig. 5, Fig. 6 from Sallinen et al., 2010
heart contraction decreased process quality, abnormal	WT + MO5-pink1	Fig. 4 from Priyadarshini et al., 2013
nucleate erythrocyte increased amount, abnormal	WT + MO5-pink1	Fig. 5 from Priyadarshini et al., 2013
pretectum dopaminergic neuron decreased amount, abnormal	WT + MO5-pink1	Fig. 6 from Sallinen et al., 2010
regulation of hypoxia-inducible factor-1alpha signaling pathway disrupted, abnormal	WT + MO5-pink1	Fig. 1 from Priyadarshini et al., 2013
regulation of reactive oxygen species metabolic process disrupted, abnormal	WT + MO5-pink1	Fig. 4 from Priyadarshini et al., 2013
regulation of superoxide dismutase activity disrupted, abnormal	WT + MO5-pink1	Fig. 1 from Priyadarshini et al., 2013
vascular endothelial growth factor signaling pathway cellular spatiotemporal quality, abnormal	WT + MO5-pink1	Fig. 2 from Priyadarshini et al., 2013

Phenotype of all Fish created by or utilizing MO5-pink1

Phenotype	Fish	Conditions	Figures
heart contraction decreased process quality, abnormal	WT + MO5-pink1	standard conditions	Fig. 4 from Priyadarshini et al., 2013
catalase activity decreased process quality, abnormal	WT + MO5-pink1	standard conditions	Fig. 4 from Priyadarshini et al., 2013
regulation of reactive oxygen species metabolic process disrupted, abnormal	WT + MO5-pink1	standard conditions	Fig. 4 from Priyadarshini et al., 2013
vascular endothelial growth factor signaling pathway cellular spatiotemporal quality, abnormal	WT + MO5-pink1	standard conditions	Fig. 2 from Priyadarshini et al., 2013
nucleate erythrocyte increased amount, abnormal	WT + MO5-pink1	chemical treatment: N-acetyl-L-cysteine	Fig. 5 from Priyadarshini et al., 2013
regulation of hypoxia-inducible factor-1alpha signaling pathway disrupted, abnormal	WT + MO5-pink1	standard conditions	Fig. 1 from Priyadarshini et al., 2013
regulation of superoxide dismutase activity disrupted, abnormal	WT + MO5-pink1	standard conditions	Fig. 1 from Priyadarshini et al., 2013
nucleate erythrocyte increased amount, abnormal	WT + MO5-pink1	standard conditions	Fig. 5 from Priyadarshini et al., 2013
brain proliferative region increased size, abnormal	WT + MO5-pink1	standard conditions	Fig. 2 from Priyadarshini et al., 2013
diencephalon dopaminergic neuron decreased amount, abnormal	WT + MO5-pink1	standard conditions	Fig. 4, Fig. 5, Fig. 6 from Sallinen et al., 2010
pretectum dopaminergic neuron decreased amount, abnormal	WT + MO5-pink1	standard conditions	Fig. 6 from Sallinen et al., 2010

Citations